Atlas Trials

Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections

Clinical trial NCT04828694 · COMPLETED

Trial details

NCT number
NCT04828694
Sponsor
BioCorRx Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Opioid-use Disorder
Start date
2022-06-17
Primary completion
2023-02-22
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.